Last winter’s respiratory syncytial virus, or RSV, season wasn’t as brutal for U.S. babies. A new study suggests two preventive tools — a maternal vaccine and a monoclonal antibody for infants — may have helped.
The 2024-25 RSV season was the first in which the vaccine and…